The guidelines put together by the New York State workers’ compensation board are crafted to support physicians, podiatrists, and other healthcare professionals in administering suitable treatment involving Thalidomide and Lenalidomide for Complex Regional Pain Syndrome (CRPS).
These guidelines from the Workers Compensation Board are designed to aid healthcare professionals in determining the right level of care for patients dealing with ankle and foot disorders.
It’s crucial to emphasize that these guidelines do not replace clinical judgment or professional experience. The final decision about care should be a collaborative effort between the patient and their healthcare provider.
Thalidomide and Lenalidomide for CRPS
The use of Thalidomide and Lenalidomide for treating Complex Regional Pain Syndrome (CRPS) is not recommended for addressing any other chronic pain syndromes, including CRPS.